-
Q&A
The FDA’s Risk-Benefit FrameworkUsing the withdrawal of Avastin’s approval for breast cancer as a case study, Mikkael A. Sekeres’ new book analyzes the U.S. drug approval process.
by Marci A. Landsmann
-
Get Involved
Healing Takes FlightAlicia and Esther Tambe honor their sister’s memory by providing travel experiences to Black women diagnosed with breast cancer.
by Thomas Celona
-
A ‘Revolution’ in Cancer Research
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Making Informed Consent Accessible
Confusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra Gordon
-
Patient and Doctor Partnerships
As more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors.
by Karon Warren
-
Exploring a New Frontier
AACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Get Involved
The Power of PlayPediatric cancer survivor Eric Newman launched the Roc Solid Foundation, which builds playsets for children who have cancer.
by Thomas Celona
-
Policy Matters
A Call to Eliminate InequitiesThe AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.
by Lisa A. Newman, MD, MPH
-
Cultural Competence in the Community
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
-
Working Toward the End of Cancer Health Disparities
AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
Cancer Talk
Cancer Today Editors’ Picks: 2024
Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
De-escalating Treatment for DCISResearch finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
Study Highlights Challenges in Pancreatic Cancer StagingMost pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles